您的位置: 首页 > 农业专利 > 详情页

Compound Chimeric Antigen Receptor (CCAR) Targeting Multiple Antigents, Compositions and Methods of Use Thereof
专利权人:
ICELL GENE THERAPEUTICS; LLC
发明人:
Yupo Ma,Kevin PINZ,Xun Jiang,Masayuki Wada,Kevin Chen
申请号:
US16753951
公开号:
US20200308541A1
申请日:
2018.10.12
申请国别(地区):
US
年份:
2020
代理人:
摘要:
In one embodiment, the present disclosure provides an engineered cell having a first chimeric antigen receptor polypeptide including a first antigen recognition domain, a first signal peptide, a first hinge region, a first transmembrane domain, a first costimulatory domain, and a first signaling domain; and a second chimeric antigen receptor polypeptide including a second antigen recognition domain, a second signal peptide, a second hinge region, a second transmembrane domain, a second co-stimulatory domain, and a second signaling domain; wherein the first antigen recognition domain is different than the second antigen recognition domain.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充